Advancing Chronic Disease Development: Insights from FDA, EMA, PMDA, CDE and other Global Regulators

Advancing Chronic Disease Development: Insights from FDA, EMA, PMDA, CDE and other Global Regulators

Tuesday, June 16, 2026 10:15 AM to 11:30 AM · 1 hr. 15 min. (America/New_York)
TBD
02: ClinicalTrialOps-Innovation08: RegPolicy-Strategy-GlobalCollaboration

Information

Chronic Disease Town Hall spotlights emerging programs and global initiatives for chronic disease drug development, outlines the current landscape, explores opportunities and challenges, and assesses strategies to boost efficiency and accelerate therapeutic innovation.
CE
ACPECMERN
Session Level
Intermediate
Featured Topics
Global Alignment in PracticeStudent and Early Career PathwayTherapeutic Pathways
Learning Objectives
Discuss the present landscape, opportunities, and challenges of chronic disease drug development; Describe emerging programs and global initiatives designed to facilitate development of chronic disease drugs; Assess various considerations and strategies to enhance the efficiency of chronic disease drug development.